Scott Lien

969 total citations
8 papers, 61 citations indexed

About

Scott Lien is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Scott Lien has authored 8 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Cancer Research and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Scott Lien's work include CAR-T cell therapy research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Scott Lien is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Scott Lien collaborates with scholars based in Canada, United States and Germany. Scott Lien's co-authors include Trevor J. Pugh, Michael St. Paul, Pamela S. Ohashi, Carlos R. Garcia-Batres, Azin Sayad, SeongJun Han, Alisha R. Elford, Samuel D. Saibil, Babak Noamani and Marcus Q. Bernardini and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Scott Lien

7 papers receiving 60 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Lien Canada 4 36 33 10 9 7 8 61
Sonia Aristín Revilla Netherlands 2 41 1.1× 32 1.0× 17 1.7× 10 1.1× 11 1.6× 4 65
Jöran Lücke Germany 5 30 0.8× 33 1.0× 18 1.8× 5 0.6× 4 0.6× 12 69
Paula Podolski Croatia 4 21 0.6× 23 0.7× 22 2.2× 13 1.4× 11 1.6× 12 63
Andrew R. Patterson United States 4 17 0.5× 27 0.8× 30 3.0× 9 1.0× 5 0.7× 6 61
Aghiad Chamdin United States 3 32 0.9× 27 0.8× 23 2.3× 8 0.9× 6 0.9× 3 54
Alla Karpova United States 2 23 0.6× 10 0.3× 11 1.1× 7 0.8× 4 0.6× 4 41
Danni Zhu China 4 40 1.1× 37 1.1× 15 1.5× 11 1.2× 10 1.4× 4 59
Michael Parappilly United States 4 26 0.7× 9 0.3× 12 1.2× 11 1.2× 5 0.7× 9 43
Jaryse Harris United States 3 29 0.8× 29 0.9× 14 1.4× 4 0.4× 3 0.4× 6 55
Raquel Gerson-Cwilich Mexico 4 41 1.1× 21 0.6× 12 1.2× 14 1.6× 8 1.1× 12 56

Countries citing papers authored by Scott Lien

Since Specialization
Citations

This map shows the geographic impact of Scott Lien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Lien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Lien more than expected).

Fields of papers citing papers by Scott Lien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Lien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Lien. The network helps show where Scott Lien may publish in the future.

Co-authorship network of co-authors of Scott Lien

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Lien. A scholar is included among the top collaborators of Scott Lien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Lien. Scott Lien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lien, Scott, Dalam Ly, S.Y. Cindy Yang, et al.. (2024). Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient. Nature Communications. 15(1). 1094–1094. 15 indexed citations
2.
Paul, Michael St., Samuel D. Saibil, SeongJun Han, et al.. (2024). Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy. Cell Reports Medicine. 5(3). 101465–101465. 9 indexed citations
3.
Paul, Michael St., Samuel D. Saibil, Scott Lien, et al.. (2020). IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function. Cancer Immunology Research. 8(3). 321–333. 28 indexed citations
4.
Veitch, Zachary, David W. Cescon, Scott Lien, et al.. (2018). Phase II (INSPIRE) trial of pembrolizumab (pembro) with serial immune and genomic profiling in patients (pts) with metastatic triple negative breast cancer (mTNBC).. Journal of Clinical Oncology. 36(15_suppl). 1094–1094. 4 indexed citations
5.
Clouthier, Derek, Cindy Yang, Scott Lien, et al.. (2017). A technical feasibility report on correlative studies from the investigator-initiated phase II study of pembrolizumab (Pembro) immunological response evaluation (INSPIRE).. Journal of Clinical Oncology. 35(15_suppl). 11607–11607. 1 indexed citations
6.
Colombo, Ilaria, Scott Lien, Cindy Yang, et al.. (2017). Immunologic and genomic characterization of high grade serous ovarian cancer (HGSOC) in patients (pts) treated with pembrolizumab (Pembro) in the phase II INSPIRE trial.. Journal of Clinical Oncology. 35(15_suppl). 5581–5581. 2 indexed citations
7.
Bailyn, Bernard, Kathleen Neils Conzen, Edward M. Cook, et al.. (2016). "True Americans" and "Hordes of Foreigners": Nationalism, Ethnicity and the Problem of Citizenship in the United States, 1789-1800. 1 indexed citations
8.
Butler, Miriam, Michael Hsing, Ari Kim, et al.. (2015). Abstract 1648: Targeting ETS factor ETV4 as a novel therapeutic for the management of breast and prostate cancer. Cancer Research. 75(15_Supplement). 1648–1648. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026